Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo
Lídia Cedó,
Sara Fernández-Castillejo,
Laura Rubió,
Jari Metso,
David Santos,
Daniel Muñoz-Aguayo,
Andrea Rivas-Urbina,
Mireia Tondo,
Karen Alejandra Méndez-Lara,
Marta Farràs,
Matti Jauhiainen,
Maria-José Motilva,
Montserrat Fitó,
Francisco Blanco-Vaca,
Rosa Solà,
Joan Carles Escolà-Gil
Affiliations
Lídia Cedó
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Sara Fernández-Castillejo
Surgery Department-Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), Faculty of Medicine and Health Sciences-Medicine, Universitat Rovira i Virgili, 43201 Reus, Spain
Laura Rubió
Surgery Department-Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), Faculty of Medicine and Health Sciences-Medicine, Universitat Rovira i Virgili, 43201 Reus, Spain
Jari Metso
Minerva Foundation Institute for Medical Research and National Institute for Health and Welfare, Genomics and Biomarkers Unit, 00290 Helsinki, Finland
David Santos
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Daniel Muñoz-Aguayo
IMIM Hospital del Mar Medical Research Institute, Grup de Risc Cardiovascular i Nutrició, 08003 Barcelona, Spain
Andrea Rivas-Urbina
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Mireia Tondo
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Karen Alejandra Méndez-Lara
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Marta Farràs
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Matti Jauhiainen
Minerva Foundation Institute for Medical Research and National Institute for Health and Welfare, Genomics and Biomarkers Unit, 00290 Helsinki, Finland
Maria-José Motilva
Instituto de Ciencias de la Vid y del Vino-ICVV (CSIC-Universidad de La Rioja-Gobierno de La Rioja), Finca “La Grajera”, 26007 Logroño, La Rioja, Spain
Montserrat Fitó
IMIM Hospital del Mar Medical Research Institute, Grup de Risc Cardiovascular i Nutrició, 08003 Barcelona, Spain
Francisco Blanco-Vaca
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
Rosa Solà
Surgery Department-Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), Faculty of Medicine and Health Sciences-Medicine, Universitat Rovira i Virgili, 43201 Reus, Spain
Joan Carles Escolà-Gil
Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo.